These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 23603458)

  • 1. Importance of epigenetic changes in cancer etiology, pathogenesis, clinical profiling, and treatment: what can be learned from hematologic malignancies?
    Vecchio L; Seke Etet PF; Kipanyula MJ; Krampera M; Nwabo Kamdje AH
    Biochim Biophys Acta; 2013 Aug; 1836(1):90-104. PubMed ID: 23603458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase CK2 in hematologic malignancies: reliance on a pivotal cell survival regulator by oncogenic signaling pathways.
    Piazza F; Manni S; Ruzzene M; Pinna LA; Gurrieri C; Semenzato G
    Leukemia; 2012 Jun; 26(6):1174-9. PubMed ID: 22289987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
    Frau M; Feo F; Pascale RM
    J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined CpG and poly I:C stimulation of monocytes results in unique signaling activation not observed with the individual ligands.
    Arsenault RJ; Kogut MH; He H
    Cell Signal; 2013 Nov; 25(11):2246-54. PubMed ID: 23876795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JAK/STAT signal transduction: regulators and implication in hematological malignancies.
    Valentino L; Pierre J
    Biochem Pharmacol; 2006 Mar; 71(6):713-21. PubMed ID: 16426581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
    McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
    Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why does tumor-associated fatty acid synthase (oncogenic antigen-519) ignore dietary fatty acids?
    Menendez JA; Colomer R; Lupu R
    Med Hypotheses; 2005; 64(2):342-9. PubMed ID: 15607569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High glucose driven expression of pro-inflammatory cytokine and chemokine genes in lymphocytes: molecular mechanisms of IL-17 family gene expression.
    Kumar P; Natarajan K; Shanmugam N
    Cell Signal; 2014 Mar; 26(3):528-39. PubMed ID: 24308966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein tyrosine phosphatases as novel targets in breast cancer therapy.
    Nunes-Xavier CE; Martín-Pérez J; Elson A; Pulido R
    Biochim Biophys Acta; 2013 Dec; 1836(2):211-26. PubMed ID: 23756181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microarray analyses of the effects of NF-kappaB or PI3K pathway inhibitors on the LPS-induced gene expression profile in RAW264.7 cells: synergistic effects of rapamycin on LPS-induced MMP9-overexpression.
    Mendes Sdos S; Candi A; Vansteenbrugge M; Pignon MR; Bult H; Boudjeltia KZ; Munaut C; Raes M
    Cell Signal; 2009 Jul; 21(7):1109-22. PubMed ID: 19285553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway.
    Polivka J; Janku F
    Pharmacol Ther; 2014 May; 142(2):164-75. PubMed ID: 24333502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astaxanthin inhibits NF-κB and Wnt/β-catenin signaling pathways via inactivation of Erk/MAPK and PI3K/Akt to induce intrinsic apoptosis in a hamster model of oral cancer.
    Kavitha K; Kowshik J; Kishore TK; Baba AB; Nagini S
    Biochim Biophys Acta; 2013 Oct; 1830(10):4433-44. PubMed ID: 23726989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concise review: roles of polycomb group proteins in development and disease: a stem cell perspective.
    Rajasekhar VK; Begemann M
    Stem Cells; 2007 Oct; 25(10):2498-510. PubMed ID: 17600113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WJD008, a dual phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin inhibitor, prevents PI3K signaling and inhibits the proliferation of transformed cells with oncogenic PI3K mutant.
    Li T; Wang J; Wang X; Yang N; Chen SM; Tong LJ; Yang CH; Meng LH; Ding J
    J Pharmacol Exp Ther; 2010 Sep; 334(3):830-8. PubMed ID: 20522531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders.
    Kauppinen A; Suuronen T; Ojala J; Kaarniranta K; Salminen A
    Cell Signal; 2013 Oct; 25(10):1939-48. PubMed ID: 23770291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
    Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C
    Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational determinants of epigenetic instablity in myeloid malignancies.
    Jankowska AM; Szpurka H
    Semin Oncol; 2012 Feb; 39(1):80-96. PubMed ID: 22289495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of mitogen-activated protein kinases and nuclear factor-κB signaling is involved in rapamycin suppression of TLR2-induced inflammatory response in monocytic THP-1 cells.
    Sun R; Zhang Y; Ma S; Qi H; Wang M; Duan J; Ma S; Zhu X; Li G; Wang H
    Microbiol Immunol; 2015 Oct; 59(10):614-22. PubMed ID: 26337526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.